Selecta Biosciences, Inc. was a big mover last session, as the company saw its shares more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.5100 –$4.0600 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Selecta Biosciences. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Selecta Biosciences has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Selecta Biosciences, Inc. Price
Investors interested in the Medical – Biomedical and Genetics industry may consider Applied Therapeutics Inc (APLT - Free Report) which has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.5 Stocks to Soar Past the Pandemic:
In addition to the companies you learned about above, we invite you to learn about 5 cutting-edge stocks that could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of the decade.
See the 5 high-tech stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Selecta Biosciences, Inc. was a big mover last session, as the company saw its shares more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.5100 –$4.0600 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Selecta Biosciences. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Selecta Biosciences has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Selecta Biosciences, Inc. Price
Investors interested in the Medical – Biomedical and Genetics industry may consider Applied Therapeutics Inc (APLT - Free Report) which has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
5 Stocks to Soar Past the Pandemic:
In addition to the companies you learned about above, we invite you to learn about 5 cutting-edge stocks that could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of the decade.
See the 5 high-tech stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on APLT - FREE